Inventor · disambiguated record
John Kastelein
Also filed as: KASTELEIN JOHN · KASTELEIN JOHN J P
5 granted patents·3 pending applications·28 citations·filing 2010–2024
79Inventor score
Files withDEZIMA PHARMA B V3NEWAMSTERDAM PHARMA B V3HAYDEN MICHAEL R1NEWAMSTERDAM PHARMA B V DUTCH REGISTRATION NO 559719461
Top patents by PatentIndex Score
8 records- 0194US11013742B2Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseasesDEZIMA PHARMA B V·Filed 2020·Granted May 25, 2021·6 cites·6 claims
- 0293US11642344B2Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseasesNEWAMSTERDAM PHARMA B V·Filed 2021·Granted May 9, 2023·5 cites·10 claims
- 0392US10300059B2Pharmaceutical composition and therapeutic combination comprising a cholesteryl ester transfer protein inhibitor and HMG CoA reductase inhibitorsDEZIMA PHARMA B V·Filed 2015·Granted May 28, 2019·11 cites·15 claims
- 0485US2025228852A1Cholesteryl ester transfer protein (cetp) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseasesNEWAMSTERDAM PHARMA B V·Filed 2024·Application pending·0 cites
- 0583US12186315B2Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseasesNEWAMSTERDAM PHARMA B V·Filed 2023·Granted Jan 7, 2025·0 cites·4 claims
- 0683US10653692B2Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseasesDEZIMA PHARMA B V·Filed 2014·Granted May 19, 2020·6 cites·10 claims
- 0758US2023041138A1Treatment of his hyporespondersNEWAMSTERDAM PHARMA B V DUTCH REGISTRATION NO 55971946·Filed 2022·Application pending·0 cites
- 0833US2011201673A1Lpl variant therapeuticsHAYDEN MICHAEL R·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Kastelein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →